Skip to main content
Sign In

University of Colorado Cancer Center

University of Colorado Cancer Center, A National Cancer Institute-designated Comprehensive Cancer Center
 

Lynn Heasley, PhD

Preceptor


Categories:

Signal pathways mediating autocrine growth of cancer cells and resistance to targeted therapeutics

Specialty:

Lung Cancer, Head and Neck Cancer, Mesothelioma

Location:

University of Colorado Anschutz Medical Campus, Department of Craniofacial Biology

Prerequisites:

Must have completed one year of college

Openings: 1

Program Objective:

To use molecular biology and pharmacological inhibitors to identify specific growth factors, receptor tyrosine kinases and signaling enzymes mediating autocrine growth of lung cancer cells as well as mechanisms of resistance to targeted therapeutics. 

Program Description:

Students will employ the following laboratory procedures:

  1. cell culture of human lung cancer and/or head and neck cancer and/or mesothelioma cell lines;
  2. transfection experiments with expression vectors to over-express or silence specific gene products such as growth factors and growth factor receptors;
  3. perform assays to assess the effect of molecular perturbations or inhibitors on receptor tyrosine kinas activity, MAP kinase and AKT signaling, cell proliferation, anchorage-independent growth, and apoptosis.  

​​

© The Regents of the University of Colorado, a body corporate. All rights reserved.

Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.